Goldman Sachs’s Jin Medical International ZJYL Stock Holding History

Goldman Sachs’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-646	Closed	-$8.4K	–	6695
2025 Q2	$8.4K	Sell	646 -5,909	-90%	-$90K	﹤0.01%	6007
2025 Q1	$97.5K	Buy	+6,555	New	+$109K	﹤0.01%	5790

Other funds holding ZJYL

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Goldman Sachs's ZJYL Position: Q3 2025 in Review

Goldman Sachs sold out of Jin Medical International (ZJYL) in Q3 2025, closing a stake of 646 shares — an estimated $8.4K sold.

Goldman Sachs first reported a position in ZJYL in Q1 2025 and held it in 2 quarters. The position peaked at $97.5K in Q1 2025. 9 funds tracked by Wall St. Rank hold ZJYL as of Q3 2025.

Goldman Sachs reported no remaining Jin Medical International position as of Q3 2025 after selling out during the quarter.
Goldman Sachs sold 646 Jin Medical International shares in Q3 2025, an estimated $8.4K.
Goldman Sachs first reported a position in Jin Medical International in Q1 2025 and held it in 2 quarters.
Goldman Sachs's Jin Medical International position peaked at $97.5K in Q1 2025.
9 funds tracked by Wall St. Rank held Jin Medical International as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.